- Home
- LI vs BNTX Comparison
LI vs BNTX Comparison
Compare LI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | BNTX |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | China | Germany |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 24.7B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LI | BNTX |
|---|---|---|
| Price | $12.11 | $96.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | $19.66 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 2.7M | 985.0K |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.98 | N/A |
| Revenue Next Year | $22.72 | $3.37 |
| P/E Ratio | $29.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.54 | $79.81 |
| 52 Week High | $26.83 | $124.00 |
Technical Indicators
Market Signals| Indicator | LI | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 44.73 |
| Support Level | $11.65 | $88.36 |
| Resistance Level | $12.56 | $98.81 |
| Average True Range (ATR) | 0.29 | 2.55 |
| MACD | 0.01 | -1.08 |
| Stochastic Oscillator | 43.51 | 9.27 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.